tirzepatide supreme court Legal Challenge Over Lilly's GLP-1 Shortages Highlights FDA's Post-Chevron Vulnerability Is Tirzepatide Legal in 2026?

While Eli Lilly and Company includes warning labels about common side effects of their dulaglutide medication, the language on the label may not have provided adequate warnings about severe health risks such as stomach paralysis, intestinal blockages, bowel obstruction, or frequent and excessive vomiting

This is because exposing a developing fetus to potential risks is a serious consideration

This business arm complements the company's consumer reach, creating new pathways for industry collaboration and innovation

For example, a provider caring for a pediatric patient may prefer a prescription compounded into an oral liquid if the medication is available only as a tablet

However, because it activates the GLP-1 pathway along with GIP and glucagon receptors researchers believe similar brain-related effects could occur

Between November 2022 and June 2023, Amarvel Biotech sold over 200 kilograms of precursor chemicals to U.S